T7009

Thrombin from human plasma

lyophilized powder, ≥1,000 NIH units/mg protein (E1%/280, 18.3)

• Synonim(y): Factor IIa
• Numer CAS: 9002-04-4
• Numer EC enzymu: 3.4.21.5 (BRENDA, IUBMB)
• Numer WE: 232-648-7
• Numer MDL: MFCD00082072
• Kod UNSPSC: 12352204
• NACRES: NA.54

Właściwości

• Postać: lyophilized powder
• Poziom jakości: 200
• aktywność właściwa: ≥1,000 NIH units/mg protein (E1%/280, 18.3)
• masa cząsteczkowa: 37.4 kDa
• zanieczyszczenia: HIV and HBsAg, source material tested negative
• numer dostępu UniProt: P00734
• Zastosowanie: diagnostic assay manufacturing
• temp. przechowywania: −20°C
• informacje o genach: human ... F2(2147)

Opis

Opis ogólny

The F2 gene encodes thrombin protein and is mapped to human chromosome 11p11.2.

Zastosowanie

Thrombin from human plasma has been:

• dissolved in CaC_l2 and added to poly ethylene glycolated fibrinogen/cell solution for fibrin production
• to polymerize fibrin on well plates
• used as an endogenous agonist proteinase for proteinase-activated receptors : PAR1, PAR3 and PAR4 for stimulation of cells

Działania biochem./fizjol.

Thrombin is an endolytic serine protease which stimulates vascular damage induced-leukocytes, platelets, endothelial and mesenchymal cell production. This action is mediated via G-protein-coupled receptor. It catalysis the cleavage of fibrinogen at Arg−Gly bonds to form fibrin and release fibrinopeptides A and B. The predominant form of thrombin in vivo is the zymogen prothrombin (factor II), which is produced in the liver. Prothrombin is a coagulation activation factor, high levels of which indicates cancer. Thrombin can be used to cleave fusion proteins. Cleavage of fusion proteins can be carried out at a thrombin:fusion protein ratio of 1:500.

Serine protease that selectively cleaves Arg-Gly bonds in fibrinogen to form fibrin and fibrinopeptides A and B.

Definicja jednostki

Activity is expressed in NIH units obtained by direct comparison to a NIH Thrombin Reference Standard

Postać fizyczna

Lyophilized from saline sodium citrate buffer, pH 6.5

Komentarz do analizy

The NIH assay procedure uses 0.2 ml diluted plasma (1:1 with saline) as a substrate and 0.1ml of thrombin sample (stabilized in a 1% buffered albumin solution) based on a modification of the method of Biggs. Only clotting times in the range of 15-25 seconds are used for determining thrombin concentrations.

Inne uwagi

View more information on thrombin at www.sigma-aldrich.com/enzymeexplorer.

Oświadczenie o zrzeczeniu się odpowiedzialności

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS08
• Hasło ostrzegawcze: Danger
• Zwroty wskazujące rodzaj zagrożenia: H334
• Zwroty wskazujące środki ostrożności: P261 - P284 - P501
• Klasyfikacja zagrożeń: Resp. Sens. 1
• Kod klasy składowania: 10 - Combustible liquids
• Klasa zagrożenia wodnego (WGK): WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable